JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (3): 76-80.doi: 10.6040/j.issn.1673-3770.0.2015.154

Previous Articles     Next Articles

In vitro study of the effect of Casein Kinase2 siRNA on anginogesis

DU Xiangge1, ZHANG Yingchun2, YAN Xin2, WANG Cui2, ZHAO Bojun2   

  1. 1. Second Clinical Medicine College, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, China;
    2. Department of Ophthalmology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2015-04-13 Revised:2015-05-13 Published:2015-06-16
  • Contact: 赵博军。E-mail:zhaobojun@hotmail.com E-mail:zhaobojun@hotmail.com

PDF (PC)

513

Abstract: Objective To prove the effect of Casein Kinase2 siRNA on vascular endothelial growth factor(VEGF) expression and the angiogenic capacity in human umbilical vein endothelial cells (HUVECs). Methods HUVECs were transfected with either Casein Kinase2 siRNA or negative control siRNA. Cell proliferation was analyzed by MTT assay; the angiogenic capacity was accessed by tube formation; cell migration was assessed by the wound-healing model. Gene and protein expressions of VEGF were examined by Real-time PCR and Western blotting methods. Results Casein Kinase2 siRNA decreased the expressions of Casein Kinase2 and declined HUVEC proliferation, tube formation and migration. It was also reduced the expression of VEGF mRNA and VEGF protein. Conclusion Our results demonstrated that Casein Kinase2 siRNA reduced the expression of VEGF and declined the capacity of angiogenesis in HUVECs.

Key words: Angiogenesis, Vascular endothelial growth factor, Casein Kinase 2, siRNA, Vascular endothelial cells

CLC Number: 

  • R774.1
[1] Campochiaro P A. Ocular neovascularization[J]. J Mol Med (Berl), 2013, 91(3):311-321.
[2] Dorrell M, Uusitalo-Jarvinen H, Aguilar E, et al. Ocular neovascularization: basic mechanisms and therapeutic advances[J]. Surv Ophthalmol, 2007, 52(1):3-19.
[3] Andrei A. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina[J]. Am J Pathol, 2006, 168(5):1722-1736.
[4] Kramerov A A, Ljubimov A V. Focus on molecules:protein kinase CK2[J]. Exp Eye Res, 2012, 8(101):111-112.
[5] Barnstable C J, Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential[J]. Prog Retin Eye Res, 2004, 23(5):561-577.
[6] Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals mir-199ab-3p as therapeutic target for hepatocellular carcinoma[J].Cancer Cell, 2011, 19(2):232-243.
[7] Ren Shancheng, Liu Yawei. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer[J]. J Urol, 2013, 190(6):2278-2287.
[8] Duncan J S, Litchfield D W. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2[J]. Biochim Biophys Acta, 2008, 1784(1):33-47.
[9] Dorrell M I, Aguilar E, Scheppke L, et al . Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis[J]. Proc Natl Acad Sci USA, 2007, 104(3):967-972.
[10] Maloney S C, Godeiro K D, Odashiro A N, et al. Current and emerging concepts in the management of neovascular age-related macular degeneration[J]. Cardiovasc Hematol Agents Med Chem, 2007, 5(2):147-154.
[11] Ljubimov A V, Caballero S, Aoki A M, et al. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization[J]. Invest Ophthalmol Vis Sci, 2004, 45(12):4583-4591.
[12] Pagano M A, Poletto G, Di Maira G, et al. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors[J]. Chembiochem, 2007, 28(1):129-139.
[13] Golub A G, Yakovenko O Y, Prykhod'ko A O, et al. Evaluation of 4, 5, 6, 7-tetrahalogeno-1H-isoindole-1, 3(2H)-diones as inhibitors of human protein kinase CK2[J]. Biochim Biophys Acta, 2008, 1784(1):143-149.
[14] Zamore P D, Tuschl T, Sharp P A, et al. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals[J]. Cell, 2000, 101(1):25-33.
[1] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[2] WANG Lixue, ZENG Yi, WANG Lixin, PENG Xianbing. Clinical observation of the effect of infiltrating Biprofen Gelatin Sponge after functional endoscopic sinus surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 16-25.
[3] XU Enpei, SUN Xianyong. Diagnosis and treatment of exudative age-related macular degeneration combined with retinal pigment epithelial detachment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 125-142.
[4] WANG Luping, KOU Fangning, WANG Hao, ZHANG Canwei, WANG Yanling, YOU Ran, WU Weizhen. Effects of subretinal hyperreflective material on the visual prognosis of anti-VEGF therapy in patients with neovascular macular degeneration [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 101-105.
[5] LI ManOverview,FENG Xue, WANG YanlingGuidance. Association between ocular ischemic syndrome and ischemic stroke [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 88-92.
[6] SONG QingOverview,SONG XichengGuidance. Research progress of anlotinib combination therapy in cancer treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 106-112.
[7] FAN Huijuan，,ZHANG Haili. Advancements of HIF-1α and VEGF in middle ear cholesteatoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 93-97.
[8] ObjectiveTo discuss the causes and appropriate treatment for iris neovascularization following the analysis of cases( eyes). MethodsIt was a retrospective case series study involving patients( eyes)with iris neovascularization diagnosed between September and July . All the patients underwent ophthalmic examination, and all the examination findings and treatments were recorded. The causes, correlative factors, and treatment outcomes of iris neovascularization were analyzed. ResultsOf the patients, ( eyes, .%)had retinal ischemic signs, including vitreous hemorrhage and retinal vascularization on fundus fluorescein angiography, ( eyes, .%)did not have retinal ischemic signs. After months of treatment, retinal vascularization resolved in all the cases, and iris neovascularization resolved completely in patients( eyes, .%), iris neovascularization was still found in patients( eyes, .%). ConclusionsAnterior segment ischemia may also lead to iris vascularization, although retinal ischemia was the main cause. Additionally, iris neovascularization may not always resolve with treatment for retinal ischemia. Finally, anti-VEGF drug injection was an effective treatment for iris neovascularization.. Case analysis of 25 cases of iris neovascularizationLI Xuan1,2, HUANG Yingxiang2 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; 2. Department of Fundus Disease and Eye Trauma, Eye Hospital China Academy of Chinese Medicine Sciences, Beijing 100040, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 41-47.
[9] LI Hao, LI Yanzhong, WANG Yan. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression in the soft palate of [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 43-47.
[10] WANG Cui, YAN Xin, ZHAO Bojun. Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 94-97.
[11] . Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(2): 90-95.
[12] LI Langen, WEI Wei, ZHANG Yufeng, Geriletu, YANG Jia, ZHANG Yanmei. The experiment of SIRT1 on against oxidative stress to retinal pigmented epithelium cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 56-59.
[13] LI Yingying, ZHOU Han, ZHANG Weiqiang, DONG Weida. Effects of silencing hypoxia inducible factor-1α on the expression of cytokines in cultured human nasal epithelial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 38-42.
[14] LI Junying. Effects of rosuvastatin combined with fenofibrate therapy on vascular endothelial function retinopathy diabetic retinopathy patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 72-75.
[15] ZHANG Ying-chun, DU Xiang-ge, YAN Xin, WANG Cui, ZHAO Bo-jun. Effect of nicotine on human RPE cells and HUVECs [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(2): 74-80.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd